Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural Pneumonectomy

被引:79
作者
Kao, Steven Chuan-Hao [1 ,2 ,3 ]
Klebe, Sonja [4 ]
Henderson, Douglas W. [4 ]
Reid, Glen [1 ,3 ]
Chatfield, Mark [3 ]
Armstrong, Nicola J. [5 ,6 ]
Yan, Tristan D. [7 ]
Vardy, Janette [2 ,3 ]
Clarke, Stephen [1 ,3 ,8 ]
van Zandwijk, Nico [1 ,3 ]
McCaughan, Brian [7 ]
机构
[1] Bernie Banton Ctr, Asbestos Dis Res Inst, Sydney, NSW, Australia
[2] Concord Repatriat Gen Hosp, Dept Med Oncol, Sydney, NSW, Australia
[3] Univ Sydney, Sydney, NSW 2006, Australia
[4] Flinders Med Ctr, Dept Anat Pathol, Adelaide, SA, Australia
[5] Garvan Inst Med Res, Canc Res Program, Sydney, NSW, Australia
[6] Univ New S Wales, Sch Math & Stat, Sydney, NSW, Australia
[7] Royal Prince Alfred Hosp, Dept Cardiothorac Surg, Sydney, NSW, Australia
[8] Royal N Shore Hosp, Dept Med Oncol, Sydney, NSW, Australia
基金
英国医学研究理事会;
关键词
Malignant pleural mesothelioma; Calretinin; Neutrophil-to-lymphocyte ratio; Prognosis; PHASE-II TRIAL; PLEURAL MESOTHELIOMA; INDUCTION CHEMOTHERAPY; PREDICTIVE ACCURACY; SURVIVAL; CISPLATIN; DIAGNOSIS; CANCER; GUIDELINES; EXPERIENCE;
D O I
10.1097/JTO.0b013e31822a3740
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Survival after extrapleural pneumonectomy (EPP) is variable in patients with malignant pleural mesothelioma (MPM), and there are no validated prognostic factors that could be used preoperatively. We investigated the calretinin and D2-40 expression and the neutrophil-to-lymphocyte ratio (NLR), an index of systemic inflammation as potential preoperative prognostic factors. Methods: Consecutive patients who underwent EPP were included in this retrospective study. Potential prognostic factors such as age, gender, histological subtype, baseline laboratory parameters including NLR, and immunohistochemical staining for calretinin and D2-40 were evaluated. Overall survival (OS) from the date of surgery was determined by the Kaplan-Meier method. The prognostic value of the variables was examined using Cox regression, and significant factors (p < 0.05) were entered into a multivariate model to determine their independent effect. Results: A total of 85 patients were included: median age 58 years; 80% men; 77% epithelial and 23% biphasic MPM. The median OS was 19.7 months. The following variables were predictive of longer OS: female gender (p = 0.02), epithelial subtype (p = 0.04), low NLR (p < 0.01), and high calretinin score (p < 0.001). In a multivariate analysis, only NLR >= 3 (hazard ratio 1.79; 95% confidence interval: 1.04-3.07; p < 0.04) and calretinin score <= 33 versus more than 67% (hazard ratio 4.72; 95% confidence interval: 1.97-11.32; p < 0.01) remained independent predictors. The addition of calretinin score increased the explained variation by 10.1%. Conclusions: Both low calretinin expression and high NLR were independently associated with poor prognosis in patients with MPM undergoing EPP, and the calretinin score seemed to improve the accuracy of the prognostic model.
引用
收藏
页码:1923 / 1929
页数:7
相关论文
共 31 条
[1]  
[Anonymous], 2004, Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs
[2]  
[Anonymous], 2007, CANC GRADING MANUAL
[3]   Symptoms and patient-reported well-being: Do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma [J].
Bottomley, Andrew ;
Coens, Corneel ;
Efficace, Fabio ;
Gaafar, Rabab ;
Manegold, Christian ;
Burgers, Sjaak ;
Vincent, Mark ;
Legrand, Catherine ;
van Meerbeeck, Jan P. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (36) :5770-5776
[4]  
CUNTOAMESTY G, 2010, 10 INT C INT MES INT, P176
[5]   Prognostic factors in patients with pleural mesothelioma: The European Organization for Research and Treatment of Cancer experience [J].
Curran, D ;
Sahmoud, T ;
Therasse, P ;
van Meerbeeck, J ;
Postmus, PE ;
Giaccone, G .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) :145-152
[6]  
DEPERROT M, 2003, LUNG CANCER, V41, pS59
[7]   The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: Implications for revision of the American Joint Committee on Cancer staging system [J].
Flores, Raja M. ;
Routledge, Tom ;
Seshan, Venkatraman E. ;
Dycoco, Joseph ;
Zakowski, Maureen ;
Hirth, Yael ;
Rusch, Valerie W. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2008, 136 (03) :605-610
[8]   Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: A phase II trial [J].
Flores, Raja M. ;
Krug, Lee M. ;
Rosenzweig, Kenneth E. ;
Venkatraman, Ennapadam ;
Vincent, Alain ;
Heelan, Robert ;
Akhurst, Tim ;
Rusch, Valerie W. .
JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (04) :289-295
[9]   Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B [J].
Herndon, JE ;
Green, MR ;
Chahinian, AP ;
Corson, JM ;
Suzuki, Y ;
Vogelzang, NJ .
CHEST, 1998, 113 (03) :723-731
[10]  
Husain AN, 2009, ARCH PATHOL LAB MED, V133, P1317, DOI 10.1043/1543-2165-133.8.1317